Abstract LB-160: A feasibility trial using molecular-guided therapy for the treatment of patients with refractory or recurrent neuroblastoma.
Year: 2013
Type: conference-abstract
Source: Cancer Research
Authors: Giselle L. Sholler, Genevieve Bergendahl, Alyssa VanderWerff, William Ferguson, William Roberts, Don Eslin, Jacqueline Kraveka, Joel Kaplan, Deanna Mitchell, Nehal Parikh, Kathleen Neville, Takamaru Ashikaga, Jeffrey Bond, Gina Hanna, Melinda Merchant, Matt Huentelman, Jason Corneveaux, Jeffrey Trent
Institutions: Van Andel Institute, Cardinal Glennon Children’s Medical Center, Rady Children's Hospital-San Diego, Arnold Palmer Hospital for Children, Medical University of South Carolina, Levine Children's Hospital, Helen DeVos Children's Hospital, Connecticut Children's Medical Center, Children's Mercy Hospital, University of Vermont, National Cancer Institute, Translational Genomics Research Institute
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2068079017